<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
  <channel>
    <title>Stein, Kenneth (19..-....)</title>
    <description><![CDATA[ Cardiologue. Professeur associé de médecine à la Cornell University (2012)

 ]]></description>
    <link>https://www.canal-u.tv/intervenants/stein-kenneth-257147519</link>
    <lastBuildDate>Wed, 08 Jun 2022 17:08:39 +0100</lastBuildDate>
    <generator>Canal-U</generator>
    <language>fr</language>
        <itunes:category text="Education"></itunes:category>
    <itunes:author >Canal-U</itunes:author>
    <itunes:explicit >No</itunes:explicit>
    <itunes:owner >
      <itunes:name>Stein, Kenneth (19..-....)</itunes:name>
      <itunes:email>contact@canal-u.tv</itunes:email>
    </itunes:owner>
          <item>
        <title>Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate : What relevant endpoints in autonomic nerve modulation therapy trials? What kind/level of evidence? Targets to meet for approval (FDA, and in EU, beyond CE mark) and reimbursement</title>
        <link>https://www.canal-u.tv/60677</link>
                  <description><![CDATA[ Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate : What relevant endpoints in autonomic nerve modulation therapy trials? What kind/level of evidence? Targets to meet for approval (FDA, and in EU, beyond CE mark) and reimbursement Investigator viewpoint: George BAKRIS, Chicago, USA - Ileana PIÑA, New York, USA Regulatory viewpoint: Andrew FARB, FDA, USA Industry viewpoint: Rob KIEVAL, CVRx, USA - Kenneth STEIN, Boston Scientific, USA Abstract : Debate : What relevant e ]]></description>
                          <pubDate>Fri, 14 Dec 2012 12:00:00 +0100</pubDate>
                <guid isPermaLink="false">https://www.canal-u.tv/60677</guid>
                  <enclosure url="https://vod.canal-u.tv/hls/cutms/,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.debate.what.relevant.endpoints.in.autonomic.nerve.modulation.therapy.trials.what.kind.level.of.evidence.targets.to.meet.for.approval.fda.and.in.eu.beyond.ce.mark.and.reimbursement_10929/2.36.cvct2012_stein_sd.mp4,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.debate.what.relevant.endpoints.in.autonomic.nerve.modulation.therapy.trials.what.kind.level.of.evidence.targets.to.meet.for.approval.fda.and.in.eu.beyond.ce.mark.and.reimbursement_10929/2.36.cvct2012_stein_bd.mp4,.urlset/master.m3u8" length="254" type="application/x-mpegurl" />
                      </item>
          <item>
        <title>Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Lunch Session 1 : Comparative effectiveness studies (Kenneth STEIN)</title>
        <link>https://www.canal-u.tv/61401</link>
                  <description><![CDATA[ MODIGLIANI Lunch Debate Session 1 - Friday November 30, 2012 THE DEVICE THERAPY TRIALISTS WORKSHOP  Chairpersons: Gaetano DE FERRARI, Pavia, ITA - Ileana PIÑA, New York, USA Webcast: Tariq AHMAD, Durham, USA  Device trial methodology, regulatory and implementation issues Advances in interventional medical devices are increasingly affecting cardiovascular therapy, just as pharmacological innovation did the generation before. Yet, designing and conducting a device trial is challenging and drug tri ]]></description>
                          <pubDate>Tue, 29 Jan 2013 12:00:00 +0100</pubDate>
                <guid isPermaLink="false">https://www.canal-u.tv/61401</guid>
                  <enclosure url="https://vod.canal-u.tv/hls/cutms/,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.lunch.session.1.approvability.issues.pathway.to.a.more.global.device.approval.process.ileana.pi.a.copie._11147/modigliani_lunchsession1_kennethstein_hd.mp4,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.lunch.session.1.approvability.issues.pathway.to.a.more.global.device.approval.process.ileana.pi.a.copie._11147/modigliani_lunchsession1_kennethstein_std.mp4,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.lunch.session.1.approvability.issues.pathway.to.a.more.global.device.approval.process.ileana.pi.a.copie._11147/modigliani_lunchsession1_kennethstein_bd.mp4,.urlset/master.m3u8" length="1313" type="application/x-mpegurl" />
                      </item>
      </channel>
</rss>
